To evaluate the utility of Gen-Probe AccuProbes for the identification of mycobacteria directly from BACTEC TB 12B vials containing acid-fast bacilli, culture results for 11,375 clinical specimens other than blood received from 1 January 1992 to 30 September 1993 were reviewed retrospectively. During this period, a total of 359 of 11,375 BACTEC vials were positive for acid-fast bacilli and were evaluated for mycobacteria with one Historically, the isolation and identification of mycobacteria have been very slow processes, taking up to 6 to 8 weeks for growth and another several weeks to months for identification. Recent advances in techniques, however, have dramatically shortened the times to both detection and identification. The radiometric BACTEC system (Becton Dickinson, Cockeysville, Md.) detects growth most rapidly (1, 4, 9, 14) . For the identification of mycobacteria, high-performance liquid chromatography (HPLC) (2), which is used primarily in research and reference laboratories, and analysis with DNA probes (5, 7, 11, 13) 6 M gordonae); in that study, 100% of M tuberculosis and M gordonae and 89% of MAC isolates were detected directly from the BACTEC vial. The specificity of the probes used in all three studies was 100%. A major limitation of the three studies was the small number of M tuberculosis cultures that were evaluated. Moreover, the probe for M kansasii was not evaluated, and to our knowledge there are no published data concerning the reliability of the latter probe for the direct identification of growth in BACTEC vials.
examined the reliabilities of the chemiluminescent DNA probes for testing growth directly from BACTEC TB vials. Evans et al. (6) evaluated the probes specific for MAC and MTBC (also referred to here as MAC and MTBC probes) on 120 positive BACT7EC TB cultures (which included 17 MTBC and 102 MAC). Sensitivities were 47% for MTBC and 90% for MAC. Thompson et al. (16) tested the MAC and MTBC probes on 60 positive BACTFEC cultures (including 21 MTBC and 19 MAC); the sensitivity of both probes was 100%.
Chapin-Robertson et al. (3) tested 98 acid-fast bacillus (AFB)-positive BACTEC cultures (82 MAC, 6 M tuberculosis, 6 M gordonae); in that study, 100% of M tuberculosis and M gordonae and 89% of MAC isolates were detected directly from the BACTEC vial. The specificity of the probes used in all three studies was 100%. A major limitation of the three studies was the small number of M tuberculosis cultures that were evaluated. Moreover, the probe for M kansasii was not evaluated, and to our knowledge there are no published data concerning the reliability of the latter probe for the direct identification of growth in BACTEC vials.
The purpose of our study was to expand upon the findings of the earlier studies by reviewing the data from a larger number of MTBC-positive BACTEC TB cultures and to determine the reliability of the M kansasii AccuProbe for the direct testing of growth from a positive BACTEC TB vial. Upon reviewing the results of the study, we have modified our protocol to achieve a more cost-effective use of probes in our laboratory.
MATERIALS AND METHODS
Specimens and specimen processing. Culture results for all specimens except blood that were received for the culture of AFB at the University of Texas Medical Branch from 1 January 1992 to 30 September 1993 were reviewed in the present study. Specimens were processed daily except Sundays. Specimens from sites contaminated with normal flora were decontaminated and were concentrated prior to inoculation by using NAC-PAC N-acetyl-L-cysteine/TB Base Solution (Alpha-Tec Systems, Irvine, Calif.) according to the manufacturer's directions. For each specimen, inoculation of the media was as follows: 0. Mycobacterial identification. The DNA probe assay was performed twice per week. Two milliliters of broth from an AFB-positive BACTEC 12B bottle was centrifuged at 3,000 x g for 15 min. The supernatant was decanted, and the pellet was used in the probe assay according to the manufacturer's procedure for growth from solid media. The probe tests performed were selected on the basis of the pigmentation of the pellet. Nonpigmented pellets were tested with probes for MTBC and MAC; pigmented pellets were tested for MAC and M. kansasii. M. gordonae probes were used only when the following observations suggested possible contamination of the cultures with M. gordonae: smooth appearance of the growth in the BACTEC bottle, shorter darkly staining AFB on smear, and dark orange pigmentation of the pellet. Single probes or other combinations of probes were occasionally tested on the basis of the patient's history (for example, if previous specimens from the patient were known to have been positive for MTBC, the newly positive culture was probed with MTBC).
For isolates not identified by probes, growth rate, pigmentation with and without exposure to light, and the following biochemical tests were used to identify the organism: niacin, arylsulfatase (3 days and 2 weeks), Tween hydrolysis, urease, nitrate reduction, sodium chloride tolerance, semiquantitative and heat-stable catalase, tellurite reduction, and growth on MacConkey agar without crystal violet (Becton Dickinson). Biochemical tests were performed by standard procedures (10 Colonies from subcultures of all probe-positive vials had morphologies consistent with the probe identification. Given the 100% specificity of GenProbe AccuProbes for identifying mycobacteria colonies and growth from BACTEC vials found in previous studies (3, 6, 8, 12, 16) , no further identification was performed on these cultures.
An additional 1 MTBC, 11 MAC, 14 M kansasii, and 34 M gordonae were isolated from BACTEC vials that were initially tested with probes for mycobacteria species other than those which were eventually recovered. Since the incorrect probe was chosen for the initial test, results for these vials were not considered false negative and were not included in calculating the percentages presented in Table 1 .
Eleven of the 359 vials evaluated contained mycobacteria other than those identifiable by probes: 1 identification, and the result should be available within 21 days of receipt of the specimen. The mycobacterial culture and identification system selected, however, must provide accurate results. In our laboratory, the BAClEC TB system is used to culture for mycobacteria; and for rapid identification during the period reviewed for the present study, growth from AFB-positive vials was tested with probes for MTBC, MAC, M. kansasii, and M. gordonae. Of 359 AFB-positive BACTEC vials, 75 of the 86 vials containing MTBC (87.2%) were identified after the initial screening of broth with probes. This percentage is much higher than the 47% reported by Evans et al. (6) Our results obtained with the MAC probe are very different from those that others have reported. In our experience, 99 (78.5%) of the 126 cultures containing MAC were initially positive by probe analysis. This percentage is much lower than the 90, 100, and 89% reported previously (3, 6, 16) . Possible explanations for our low percentage include the GIs of falsenegative vials and the centrifugation conditions used to prepare pellets for probe analysis.
Although a low GI certainly could be a factor, our analysis did not show a definite correlation between GI and a positive or a negative initial MAC probe result. For vials that were positive on initial testing, the GIs ranged from 18 to >999. The GIs of false-negative vials ranged from 108 to >999, 67% had GIs of >500, and 52% had GIs of >999. There was a similar lack of correlation between the GI and the initial probe result for the other species.
The centrifugation conditions that we used to prepare the pellets for probe analysis (3,000 x g for 15 min) differed from those used in the three previous studies (15,000 or 13,000 x g for 15 min or 10,000 x g for 5 to 7 min). The lower centrifugal force used in our protocol may have adversely affected the recovery and identification of organisms from broth cultures. In laboratories such as ours where a high-speed centrifuge is not currently available, increasing the centrifugation time may compensate for the lower centrifugal force. To address this possibility, we have recently doubled the centrifugation time in our protocol.
In our experience with the M. gordonae probe, 85.9% of isolates were detected upon initial screening of the BACTEC broth. This is lower than the 100% detected by ChapinRobertson et al. (3); however, there were only six M. gordonae in that study, making comparison of the results difficult.
To date, data concerning the reliability of the M. kansasii AccuProbe have come from studies in which the probe was used for culture confirmation only. LeBrun et al. (12) , who evaluated nine isolates of M. kansasii, reported probe sensitivities of 44%. Surprisingly, our detection rate when we used the probe for direct testing from a BACTEC TB vial was much higher (91.7%). However, the number of M. kansasii isolates in both studies (12 and 9) was small. In addition, the currently recommended incubation time for the selection step with the M. kansasii probe is 8 min, whereas it was 5 min in the study by LeBrun et al. (12) . According to the manufacturer, this change was made to increase specificity, but it also may have an impact on sensitivity.
Given the current emphasis on cost containment in the health care industry, the selection of a rapid, cost-efficient protocol for the detection and identification of mycobacteria is desirable. Although the BACTEC TB system is more expensive than conventional media and requires more time, its increased sensitivity and rapid growth detection improves patient care, justifying the higher cost. Use of the AccuProbes with the BACTEC TB system provides the most rapid means of identification, but the probes can and should be used in a more cost-effective manner than the approach that we have been using in our laboratory. The protocol that we recently adopted is the following (illustrated in Fig. 1) . Growth resulting in a nonpigmented pellet is tested first with the MTBC probe; if it is MTBC negative, the pellet is then tested with the MAC probe. Growth resulting in a pigmented pellet is tested with the MAC probe when the growth is from a tissue specimen, in which the presence of MAC is likely to represent disease. All other isolates are identified from solid media with probes or by biochemical tests.
Discontinuation of the routine use of the MAC probe on pigmented pellets is supported by our experience that few MAC isolates are pigmented and that the probe identified only 78.6% of MAC isolates directly from BACTEC vials. Discontinuation of the use of the M. kansasii probe is justified on the basis of the small number of isolates. Finally, discontinuation of the use of the M. gordonae probe is reasonable because this organism is almost always considered a contaminant and therefore does not require the rapid detection provided by the use of probes on BACTEC broth cultures.
In conclusion, use of the BACTEC TB-AccuProbe combination is a simple, relatively reliable method for the rapid identification of the mycobacteria most commonly encountered in the clinical laboratory. However, review of our 19-month experience suggests that the testing protocol may be improved by modifying the technique for preparing pellets for probe analysis by increasing either centrifugation speed or time and limiting the use of probes as outlined in Fig. 1 to rapidly detect M. tuberculosis while minimizing the cost to the laboratory and the patient.
